美股異動|名創優品盤前升3% 強化IP戰略定位獲機構看好
名創優品(MNSO.US)盤前升3.06%報19.87美元。華泰證券發研報指,參加了名創優品舉辦的2024全球品牌戰略升級成果發佈會。此次發佈會公司進一步強化了IP戰略定位,計劃構建“全球IP聯名集合店”,並通過Miniso Land、主題店、快閃店等體驗型店態,加快IP商品對國內外渠道的升級賦能,並輔以商管合作及加盟商扶持機制的優化。該行看好Q4伴隨哈利波特IP商品放量及海外旺季銷售帶動業績增速環比向好,以及中長期IP戰略顯效帶動盈利能力穩步提升。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.